Taejoon Pharm's margin policy draws much flak

Controversy is rising over an arbitrary notification by Taejoon Pharm, a leading eye drug maker in Korea, that the average wholesaler margin of an imported drug from Japan will be reduced by two percent from the current 7.5 percent level, industry observers said recently.

The Korea Drug Wholesalers Association has expressed its deep regret over the company's decision, saying that necessary m...